Hims & Hers Health (HIMS) Invested Capital (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Invested Capital came in at $446.2 million in Q1 2026, down 18.77% year-on-year from $549.3 million in Q1 2025, and down 18.07% quarter-over-quarter from $544.6 million in Q4 2025.
Hims & Hers Health (HIMS) Invested Capital (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Invested Capital across 8 years of filings, most recently posting $446.2 million for Q1 2026.
- Invested Capital for Q1 2026 came in at $446.2 million, down 18.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $446.2 million (down 18.77% YoY), and the FY2025 annual result was $544.6 million, up 14.23% from the prior year.
- Invested Capital came in at $446.2 million for Q1 2026 at Hims & Hers Health, down from $544.6 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $581.0 million in Q3 2025 to a low of $311.7 million in Q4 2022.
- The 5-year median for Invested Capital is $351.9 million (2024), against an average of $408.7 million.
- Across the five-year window, Invested Capital surged 56.09% in 2025 and retreated 18.77% in 2026, its largest moves.
- Hims & Hers Health's Invested Capital stood at $311.7 million in 2022, then rose by 12.73% to $351.4 million in 2023, then soared by 35.65% to $476.7 million in 2024, then advanced by 14.23% to $544.6 million in 2025, then decreased by 18.07% to $446.2 million in 2026.
- The last three Invested Capital figures came in at $446.2 million (Q1 2026), $544.6 million (Q4 2025), and $581.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 479.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.79 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 108.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446.17 Mn |
| Dec 31, 2025 | 544.57 Mn |
| Sep 30, 2025 | 580.98 Mn |
| Jun 30, 2025 | 562.70 Mn |
| Mar 31, 2025 | 549.26 Mn |
| Dec 31, 2024 | 476.72 Mn |
| Sep 30, 2024 | 440.05 Mn |
| Jun 30, 2024 | 361.97 Mn |
| Mar 31, 2024 | 351.89 Mn |
| Dec 31, 2023 | 351.44 Mn |
| Sep 30, 2023 | 335.42 Mn |
| Jun 30, 2023 | 324.85 Mn |
| Mar 31, 2023 | 312.75 Mn |
| Dec 31, 2022 | 311.74 Mn |
| Sep 30, 2022 | 323.92 Mn |
| Jun 30, 2022 | 332.03 Mn |
| Mar 31, 2022 | 340.69 Mn |
| Dec 31, 2021 | 377.45 Mn |
| Sep 30, 2021 | 378.36 Mn |
| Jun 30, 2021 | 293.05 Mn |